AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 132 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $153,000 | -21.5% | 10,617 | +14.3% | 0.00% | -50.0% |
| Q3 2019 | $195,000 | +19400.0% | 9,291 | +14193.8% | 0.00% | – |
| Q2 2019 | $1,000 | -66.7% | 65 | -54.2% | 0.00% | – |
| Q4 2018 | $3,000 | -99.5% | 142 | -99.2% | 0.00% | -100.0% |
| Q1 2018 | $561,000 | +2450.0% | 17,612 | +1917.4% | 0.01% | – |
| Q3 2017 | $22,000 | – | 873 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|